Condition
Migraine
ClinicalTrials.gov condition label
Clinical trials
24 shownNIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar DisorderNCT05669703 · 2023-11-03
RECRUITINGOptical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)NCT07720765 · 2023-10-09
RECRUITINGHeadache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online StudyNCT07817446 · 2026-11-01
NOT_YET_RECRUITINGBiological Profiles of Neuropeptides, Neurotrophins and miRNA in MigraineNCT07832032 · 2026-09-17
NOT_YET_RECRUITINGThe Sequestration of Holistic Stress Management Techniques for AdultsNCT06098755 · 2026-01-26
WITHDRAWNComputer Game, Qualitative, and MEG/EEG Assessment of Serotonergic PsychedelicsNCT06624137 · 2024-12-12
TERMINATEDThe Living With a Long-Term Condition StudyNCT06072287 · 2023-06-28
UNKNOWNRELAXaHEAD for Headache Patients (Phase II)NCT05466682 · 2022-06-09
COMPLETEDQuest to Analyze One Thousand Humans MeditatingNCT06583395 · 2021-12-05
ENROLLING_BY_INVITATIONA Study to Evaluate White Matter Hyperintensities in MigraineNCT05112289 · 2021-08-16
ACTIVE_NOT_RECRUITINGA Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderNCT04041284 · 2019-09-13
COMPLETEDA Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseNCT04031469 · 2019-07-11
SUSPENDEDImpact of Exercise on "Invisible" Symptoms and Quality of Life in Multiple Sclerosis IndividualsNCT03768830 · 2018-10-01
COMPLETEDRELAXaHEAD for Headache Patients (Phase I)NCT03183791 · 2017-11-01
COMPLETEDLSFG-SKIN, Laser Speckle FlowgraphyNCT03660618 · 2017-05-23
TERMINATEDVery Low Calories Ketogenic Diet in Migraine.NCT03076060 · 2017-01-01
COMPLETEDA Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation PowderNCT02905227 · 2016-09-01
COMPLETEDQuality Improvement and Practice Based Research in Neurology Using the EMRNCT02670161 · 2016-05-01
ENROLLING_BY_INVITATIONA Complex Contraception RegistryNCT02219269 · 2014-06-01
COMPLETEDEvaluation of an Integrated Care ProjectNCT01854580 · 2013-03-01
COMPLETEDDiet and Migraine StudyNCT01859052 · 2012-07-01
TERMINATEDBehavioral Weight Loss as a Treatment for Migraine in Obese WomenNCT01197196 · 2012-06-01
COMPLETEDEvaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough PainNCT00228605 · 2005-03-01
COMPLETEDExploring the Comorbidity Between Mental Disorders and General Medical ConditionsNCT03847753 · 2000-01-01
COMPLETEDCommon interventions
Monitored Usual Care (MUC)BEHAVIORAL2PlaceboDRUG2Advanced multi-component meditation practiceBEHAVIORAL1AHA diet recommendationsOTHER1Behavioral DisordersOTHER1Behavioral Weight Loss InterventionBEHAVIORAL1Brain NeuroimagingDIAGNOSTIC_TEST1CVT-427 (zolmitriptan inhalation powder)DRUG1Developmental DisordersOTHER1Eating DisordersOTHER1Exercise trainingBEHAVIORAL1FremanezumabDRUG1gender-affirming hormone therapyDRUG1Gender-Affirming SurgeryPROCEDURE1HIV Pre-Exposure ProphylaxisDRUG1Holistic Medicine (HM)BEHAVIORAL1Intellectual DisordersOTHER1Ketogenic dietBEHAVIORAL1laser speckle flowgraphyDEVICE1Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)DRUG1Living with LTC QuestionnaireDIAGNOSTIC_TEST1Low calorie low fat dietOTHER1Low carbohydrate dietOTHER1Migraine EducationOTHER1Mood disordersOTHER1
Leading sponsors
NYU Langone Health2Acorda Therapeutics1Cephalon1Charite University, Berlin, Germany1Chulalongkorn University1Endeavor Health1Goddess Zena I. Jones1IRCCS San Raffaele1Johns Hopkins University1King's College London1Mayo Clinic1National Institute of Mental Health (NIMH)1Nordlandssykehuset HF1ProgenaBiome1Randy Kardon1
Trial status mix
COMPLETED11
TERMINATED3
ENROLLING_BY_INVITATION2
NOT_YET_RECRUITING2
RECRUITING2
ACTIVE_NOT_RECRUITING1
SUSPENDED1
UNKNOWN1
WITHDRAWN1
Phase mix
NA9
PHASE42
PHASE11
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.